The global smoking cessation market is growing due to growing awareness about health problems associated with smoking and growing acceptance rate of smoking cessation products. On the basis of products, the electronic cigarette segment is expected to grow with the fastest rate during the forecasted period. Nicotine gums led the nicotine replacement therapy market; however, the nicotine lozenges are expected to grow with the fastest rate during the projected period. The innovation of products with better efficacy is also expected to pose as an opportunity for growth of the market. The massive unexplored market of smoking cessation industry in the developing economies is creating abundant growth opportunities for the global market.
Explore Report at: https://www.psmarketresearch.com/market-analysis/smoking-cessation-market
Some of the major trends in the market are increasing number of collaborations and partnerships, growing number of merger and acquisitions, and growing number of product launches. Tobacco addition can lead to various serious health problems. Smoking cessation is the process of discontinuing tobacco smoking and it helps to reduce the risk of smoking related diseases. Nicotine withdrawal symptoms may include feeling hungrier than usual, having trouble thinking, craving for tobacco products, and feeling irritable, anxious and angry. According to the Centre for Disease Control and Prevention in 2010, approximately 7 out of every 10 adult cigarette smokers wanted to quit smoking completely.
Some of the factors driving the growth of the global smoking cessation market are increasing number of smokers, stringent laws for smoking such as ban on smoking in public place, increasing government initiatives by distribution of smoking cessation products and higher taxes on tobacco products. In addition, the increasing initiatives to create awareness about smoking health hazards, increasing incidence of lung cancer and other diseases such as cardiac diseases and respiratory disorders due to smoking, and increasing research and development for innovation of smoking cessation products are also fueling the growth of the global market. However, the reluctance in adoption of smoking cessation products, strict regulatory requirements for electronic cigarette as medical device, restrictions and bans on the usage of electronic cigrrate, and lack of awareness of nicotine de-addiction products are some of the factors restraining the growth of the global market.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/smoking-cessation-market/toc-sample
Some of the companies operating in the global smoking cessation market are Johnson & Johnson Limited, GlaxoSmithKline PLC, Sanofi, Pfizer, Actavis Inc., Imperial Tobacco Company of India Limited, Cipla Ltd., Takeda Pharmaceuticals Co. Ltd., Imperial Tobacco Company, Revolymer Limited, McNeil AB, Boehringer Ingelheim Gmbh, Sun Pharmaceutical Industries Inc., and Novartis Inernational Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)